Laurus Labs Limited (LAURUSLABS.NS)
INR 561.25
(-2.3%)
INR 561.25
(-2.3%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 7.98 Billion INR | -0.08% |
| 2022 | 7.98 Billion INR | 25.61% |
| 2021 | 6.35 Billion INR | 39.64% |
| 2020 | 4.55 Billion INR | 145.41% |
| 2019 | 1.85 Billion INR | -28.27% |
| 2018 | 2.58 Billion INR | 82.63% |
| 2017 | 1.41 Billion INR | 13.73% |
| 2016 | 1.24 Billion INR | -72.96% |
| 2015 | 4.6 Billion INR | 52.51% |
| 2014 | 3.02 Billion INR | 60.51% |
| 2013 | 1.88 Billion INR | 173.89% |
| 2012 | 687.03 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 6.61 Billion INR | 0.0% |
| 2023 FY | 7.98 Billion INR | -0.08% |
| 2023 Q4 | 7.98 Billion INR | 0.0% |
| 2023 Q2 | 6.93 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 7.98 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 7.98 Billion INR | 25.61% |
| 2022 Q2 | 5.77 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 6.35 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 5.54 Billion INR | 0.0% |
| 2021 FY | 6.35 Billion INR | 39.64% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 4.55 Billion INR | 145.41% |
| 2020 Q4 | 4.55 Billion INR | 0.0% |
| 2020 Q2 | 1.77 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q2 | 2.31 Billion INR | 0.0% |
| 2019 FY | 1.85 Billion INR | -28.27% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 1.85 Billion INR | 0.0% |
| 2018 Q4 | 2.58 Billion INR | 0.0% |
| 2018 FY | 2.58 Billion INR | 82.63% |
| 2018 Q2 | 2.91 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 FY | 1.41 Billion INR | 13.73% |
| 2017 Q2 | 1.4 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 1.41 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 1.24 Billion INR | 0.0% |
| 2016 FY | 1.24 Billion INR | -72.96% |
| 2016 Q2 | 2.82 Billion INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 FY | 4.6 Billion INR | 52.51% |
| 2014 FY | 3.02 Billion INR | 60.51% |
| 2013 FY | 1.88 Billion INR | 173.89% |
| 2012 FY | 687.03 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -1169.45% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -7323.186% |
| FDC Limited | 2.46 Million INR | -323594.242% |
| Gufic Biosciences Limited | 1.53 Billion INR | -418.455% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 74.796% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -468.91% |
| Orchid Pharma Limited | 1.2 Billion INR | -562.818% |
| Alkem Laboratories Limited | 400 Million INR | -1895.575% |
| Bajaj HealthCare Limited | 650.34 Million INR | -1127.395% |
| Brooks Laboratories Limited | 3.56 Million INR | -223807.433% |
| Eris Lifesciences Limited | 6.54 Billion INR | -21.959% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -5307.696% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | -579.692% |
| Innova Captab Limited | 2.1 Billion INR | -279.171% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -10462.789% |
| Wanbury Limited | 820 Million INR | -873.451% |
| Lupin Limited | 1.55 Billion INR | -414.058% |
| Aarti Drugs Limited | 2.75 Billion INR | -189.918% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -1995475.0% |
| Albert David Limited | 6.01 Million INR | -132584.508% |
| Alembic Limited | 73.9 Million INR | -10701.488% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Hester Biosciences Limited | 1.81 Billion INR | -339.136% |
| Hikal Limited | 4.22 Billion INR | -88.774% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -7050.933% |
| Ind-Swift Limited | 10.09 Billion INR | 20.928% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -5877.415% |
| Medico Remedies Limited | 8.67 Million INR | -91946.817% |
| Morepen Laboratories Limited | 33.64 Million INR | -23628.597% |
| Procter & Gamble Health Limited | 68.8 Million INR | -11502.18% |
| RPG Life Sciences Limited | -30.3 Million INR | 26444.224% |
| Sigachi Industries Limited | 265.79 Million INR | -2903.145% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -59917.293% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -3658.924% |
| Themis Medicare Limited | 267.74 Million INR | -2881.363% |
| Unichem Laboratories Limited | 382.22 Million INR | -1988.399% |
| Vaishali Pharma Limited | 35.98 Million INR | -22083.531% |
| Venus Remedies Limited | 386.8 Million INR | -1963.676% |
| Windlas Biotech Limited | 20.18 Million INR | -39455.5% |
| ZIM Laboratories Limited | 356 Million INR | -2142.181% |
| Sakar Healthcare Limited | 549.55 Million INR | -1352.516% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 62.61% |
| Divi's Laboratories Limited | 20 Million INR | -39811.5% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -28576.175% |
| Mankind Pharma Limited | 325.81 Million INR | -2349.949% |
| Sequent Scientific Limited | 1.42 Billion INR | -459.302% |
| Neuland Laboratories Limited | 449.2 Million INR | -1676.98% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -3276.607% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -426.221% |
| Zydus Lifesciences Limited | 251 Million INR | -3080.199% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -57047.05% |
| Wockhardt Limited | 8.91 Billion INR | 10.412% |
| Bal Pharma Limited | 363.82 Million INR | -2094.0% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | -33.26% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -2142.71% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -86664.13% |
| Shilpa Medicare Limited | 5.6 Billion INR | -42.5% |
| Valiant Laboratories Limited | 750.89 Million INR | -963.032% |
| Ajanta Pharma Limited | 235.2 Million INR | -3293.835% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -24656.103% |
| Granules India Limited | 689.71 Million INR | -1057.341% |
| Medicamen Biotech Limited | 12.55 Million INR | -63478.654% |
| Ipca Laboratories Limited | 5.8 Billion INR | -37.529% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 654923.626% |
| Piramal Enterprises Limited | 535.85 Billion INR | 98.51% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 50.235% |
| NATCO Pharma Limited | 53 Million INR | -14960.943% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -335.003% |
| Strides Pharma Science Limited | 6.71 Billion INR | -18.873% |
| Indoco Remedies Limited | 3.51 Billion INR | -126.944% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -7388.086% |